← FDA Drug Approvals (Drugs@FDA)
IBANDRONATE SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2014-09-02
Drug application
- FDA Application #
ANDA202671- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- IBANDRONATE SODIUM
- Generic name
- IBANDRONATE SODIUM
- Active ingredients
- IBANDRONATE SODIUM
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- PHARMOBEDIENT
- Manufacturer
- Mylan Institutional LLC
- First approval
- 2014-09-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown